Promising recent developments in materials science and processing have enabled the efforts on the design and development of novel “artificial muscles”, using dielectric elastomer actuators (DEAs).
71.1% of Microsoft shares are owned by institutional investors. 18.0% of Artificial Life shares are owned by company insiders. Comparatively, 0.0% of Microsoft shares are owned by company insiders.